CD4 and neoplasm: Preferential higher expression of PD-1 in treated animals may partially explain why CD4+ cell depletion resulted in more enhanced tumor suppression than the isotype control treatment (Figure 4A), since PD-1 expressing CD4+ T cells might have contributed to the immunosuppressive status in the TME/TDLNs and systemic immune compartment.